LFST logo

LFSTLifeStance Health Group Inc

$7.41
$0.23
(3.01%)
Today
Closed $7.41
$0.26
(3.51%)
After Hours
Updated: 07:08 PM EDT
Reported EarningsMay 7
Mkt Cap$2.96B
Vol1.92M
News
all
press releases
ENSG Expands Healthcare Footprint With Iowa, California Acquisitions
With new acquisitions in California and Iowa, Ensign Group has grown its portfolio to 396 healthcare operations and 181 owned real estate properties.
Zacks
News Placeholder
More News
News Placeholder
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
News Placeholder
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for LifeStance Health (LFST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks
News Placeholder
SEM Expands Rehab Footprint With New Virginia Hospital Joint Venture
Select Medical and Carilion Clinic plan a 50-bed rehab hospital in Virginia as demand continues to grow.
Zacks
News Placeholder
Earnings Estimates Rising for LifeStance Health (LFST): Will It Gain?
LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
News Placeholder
LifeStance Health Group (LFST) is a Great Momentum Stock: Should You Buy?
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
News Placeholder
Wall Street Analysts See a 31.02% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
The consensus price target hints at a 31% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
News Placeholder
Why LifeStance Health Group Zoomed 20% Higher Today
Key PointsThis was strongly evidenced by its 21% revenue increase in the first quarter...
Nasdaq News: Markets
News Placeholder
LifeStance Health Group, Inc. Q1 Earnings Summary
(RTTNews) - Below are the earnings highlights for LifeStance Health Group, Inc. (LFST...
Nasdaq News: Markets
News Placeholder
Can Execution and Volume Trends Support DaVita's Q1 Earnings?
DVA's first-quarter 2026 results may face seasonal volume and RPT headwinds, but cost discipline, reimbursement growth and IKC contributions could aid results.
Zacks
<
1
2
...
>

Advertisement|Remove ads.